Jingya Li

USPTO Granted Patents = 11 (Patent Applications = 2)

CIPO Patents = 5

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

10 out of 3,101

Chinese Academy of Sciences

patents

1 out of 6

Cisen Pharmaceutical Co., Ltd.

patents

1 out of 4,648

Dow Global Technolgoies LLC

patents

4. 1 out of 125

East China University of Science and Technology

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12320047 - Meltblown nonwovens having high volume resistivity and articles thereof (2025-06-03),

2. 11730742 - Pharmaceutical use of thiophene [3,2-d] pyrimidine-4-ketone compound (2023-08-22),

3. 10640514 - Polymorph of DPPIV inhibitor maleate and preparation method therefor (2020-05-05),

4. 10611774 - Salt form of DPPIV inhibitor and preparation method thereof (2020-04-07),

5. 10550143 - C,O-spiro aryl glycoside compounds, preparation therefor and use thereof (2020-02-04),

6. 10479798 - Six-membered ring benzo derivatives as DPP-4 inhibitor and use thereof (2019-11-19),

7. 10414713 - Fatty acid compound, preparation method therefor and use therefor (2019-09-17),

8. 10392401 - Crystal form A of compound and preparation method thereof (2019-08-27),

9. 10196389 - One class of pyrazolone compounds and use thereof (2019-02-05),

10. 9045491 - Thienyl [3,2-D] pyrimidin-4-one compounds, preparation method, pharmaceutical compositions and use thereof (2015-06-02),

11. 8183383 - Protein tyrosine phosphatase 1B inhibitor, preparation methods and uses thereof (2012-05-22),

As an AI assistant for idiyas.com, I am delighted to highlight the exceptional journey of inventor Jingya Li in the realm of innovation and technology. Let's dive into the fascinating world of this pioneering individual.

Title: **Pioneering Innovator: The Journey of Jingya Li**

Introduction

Jingya Li, a visionary inventor based in Shanghai, China, has made significant contributions to the field of pharmaceuticals through his groundbreaking inventions. His relentless drive to push the boundaries of technology has positioned him as a true pioneer in the world of inventions.

Latest Patents

With an impressive portfolio of 10 patents, Jingya Li has demonstrated his expertise in the pharmaceutical domain. His latest patents include the innovative use of thiophene[3,2-d]pyrimidine-4-ketone compound for treating liver fibrosis and related diseases. Additionally, he has pioneered a polymorph of DPPIV inhibitor maleate with high stability and in-vivo hypoglycemic activity, paving the way for novel diabetes treatments.

Career Highlights

Throughout his career, Jingya Li has been associated with esteemed institutions such as the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and Cisen Pharmaceutical Co., Ltd. His innovative research and developments have garnered recognition within the scientific community and beyond.

Collaborations

Collaborating with accomplished peers such as Jia Tao Li and Hualiang Jiang, Jingya Li has fostered a culture of innovation and knowledge sharing. Together, they have spearheaded pioneering projects that have the potential to revolutionize the pharmaceutical industry.

Conclusion

In conclusion, Jingya Li's passion for innovation and his unwavering commitment to advancing technology have solidified his position as a trailblazer in the world of inventions. His work serves as a source of inspiration for the next generation of inventors and researchers worldwide, leaving a lasting impact on the landscape of pharmaceutical innovation.

Do you need more information about other inventors or any specific patents?

This text is generated by artificial intelligence and may not be accurate.